Objective To develop guidance on the use of coronavirus disease 2019 (COVID-19)
vaccines in patients with autoimmune rheumatic diseases (ARD). Methods The Canadian …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …

Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Background Although patients with rheumatic and musculoskeletal diseases (RMDs) are at
increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Objective To identify the factors that affect coronavirus disease 2019 (COVID-19) vaccine
decision making among individuals diagnosed with a rheumatologic condition, given that …

Background: We examined attitudes toward the COVID-19 vaccine, potential factors
underlying these attitudes, and ways to increase vaccination willingness in autoimmune …

Data regarding COVID-19 vaccine efficacy and adverse events (AE) in patients with
autoimmune and inflammatory rheumatic diseases (AIIRD) have been published recently …

Objective The goal of this study was to ascertain COVID‐19 vaccine uptake, reasons for
hesitancy, and self‐reported flare in a large rheumatology practice‐based network. Methods …